Craig-Hallum Maintains CareDx(CDNA.US) With Buy Rating

Craig-Hallum analyst William Bonello maintains $CareDx(CDNA.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 75.0% and a total average return of 39.3% over the past

Futu NewsJun 4 21:32

Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients

Surveillance Monitoring with Both AlloSure Kidney and the AlloView AI-Enabled Risk Prediction Model Improves the Detection of All Types of Allograft Rejection AlloSure Kidney Detected Subclinical Rejection in

BusinesswireJun 3 19:05

CaredX Inc.: Jefferies underwrites under a purchase rating assumption; target share price is $17 to $12

CaredX Inc.: Jefferies underwrites under a purchase rating assumption; target share price is $17 to $12

Zhitong FinanceJun 3 13:08

Express News | CareDx Inc : Jefferies Assumes Coverage With Buy Rating; Price Target $17 Vs $12

BreakingsJun 3 13:07

Decoding 6 Analyst Evaluations For CareDx

Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on CareDx (NASDAQ:CDNA) in the last three months.The table below summarizes their recent ratings, s

BenzingaJun 1 02:01

HC Wainwright & Co. : Reiterates CaredX (CDNA.US) neutral rating.

HC Wainwright & Co. : Reiterates CaredX (CDNA.US) neutral rating.

Zhitong FinanceJun 1 02:01